Antigen Receptor–Induced Activation and Cytoskeletal Rearrangement Are Impaired in Wiskott-Aldrich Syndrome Protein–Deficient Lymphocytes
暂无分享,去创建一个
K. Siminovitch | S. Grinstein | A. Nagy | J. Penninger | I. Kozieradzki | A. Shehabeldin | Jinyi Zhang | M. McGavin | A. Somani | J. Butler | L. A. da Cruz | Antonio O. dos Santos | Amro Shehabeldin
[1] Laura M. Machesky,et al. Scar1 and the related Wiskott–Aldrich syndrome protein, WASP, regulate the actin cytoskeleton through the Arp2/3 complex , 1998, Current Biology.
[2] M. Davis,et al. A receptor/cytoskeletal movement triggered by costimulation during T cell activation. , 1998, Science.
[3] Shiro Suetsugu,et al. WAVE, a novel WASP‐family protein involved in actin reorganization induced by Rac , 1998, The EMBO journal.
[4] A. Weiss,et al. A Nck‐Pak1 signaling module is required for T‐cell receptor‐mediated activation of NFAT, but not of JNK , 1998, The EMBO journal.
[5] C. Saxe,et al. SCAR, a WASP-related Protein, Isolated as a Suppressor of Receptor Defects in Late Dictyostelium Development , 1998, The Journal of cell biology.
[6] Patricia L. Widder,et al. A Novel Adaptor Protein Orchestrates Receptor Patterning and Cytoskeletal Polarity in T-Cell Contacts , 1998, Cell.
[7] Brian J. Stevenson,et al. The WASp homologue Las17p functions with the WIP homologue End5p/verprolin and is essential for endocytosis in yeast , 1998, Current Biology.
[8] R. Badolato,et al. Monocytes from Wiskott-Aldrich patients display reduced chemotaxis and lack of cell polarization in response to monocyte chemoattractant protein-1 and formyl-methionyl-leucyl-phenylalanine. , 1998, Journal of immunology.
[9] Philip R. Cohen,et al. Wiskott-Aldrich syndrome protein-deficient mice reveal a role for WASP in T but not B cell activation. , 1998, Immunity.
[10] Dunn,et al. Chemotaxis of macrophages is abolished in the Wiskott‐Aldrich syndrome , 1998, British journal of haematology.
[11] M. Davis,et al. Visualizing the dynamics of T cell activation: intracellular adhesion molecule 1 migrates rapidly to the T cell/B cell interface and acts to sustain calcium levels. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[12] K. Tedford,et al. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor , 1998, Current Biology.
[13] T. Takenawa,et al. Direct binding of the verprolin-homology domain in N-WASP to actin is essential for cytoskeletal reorganization. , 1998, Biochemical and biophysical research communications.
[14] Yoshimi Takai,et al. Induction of filopodium formation by a WASP-related actin-depolymerizing protein N-WASP , 1998, Nature.
[15] A. Nagy,et al. Embryonic stem cells, creating transgenic animals. , 1998, Methods in cell biology.
[16] M. Gallego,et al. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation , 1997 .
[17] R. Zamoyska,et al. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. , 1997, Immunity.
[18] O. Majdic,et al. Expression of Wiskott-Aldrich syndrome protein (WASP) gene during hematopoietic differentiation. , 1997, Blood.
[19] K. Siminovitch,et al. Flow cytometric analysis of platelets from childrenwith the Wiskott‐Aldrich syndrome reveals defects in platelet development, activation and structure , 1997, British journal of haematology.
[20] M. Gallego,et al. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. , 1997, Blood.
[21] C. Der,et al. Lck regulates Vav activation of members of the Rho family of GTPases , 1997, Molecular and cellular biology.
[22] Rong Li,et al. Bee1, a Yeast Protein with Homology to Wiscott-Aldrich Syndrome Protein, Is Critical for the Assembly of Cortical Actin Cytoskeleton , 1997, The Journal of cell biology.
[23] H. Ochs,et al. Tyrosine kinase signaling regulates Wiskott-Aldrich syndrome protein function, which is essential for megakaryocyte differentiation. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[24] K. Schuebel,et al. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product , 1997, Nature.
[25] R C Lovering,et al. Evidence that the Wiskott-Aldrich syndrome protein may be involved in lymphoid cell signaling pathways. , 1996, Journal of immunology.
[26] P. Finan,et al. Identification of Regions of the Wiskott-Aldrich Syndrome Protein Responsible for Association with Selected Src Homology 3 Domains* , 1996, The Journal of Biological Chemistry.
[27] R. Rickles,et al. Identification of Itk/Tsk Src Homology 3 Domain Ligands* , 1996, The Journal of Biological Chemistry.
[28] K. Miura,et al. N‐WASP, a novel actin‐depolymerizing protein, regulates the cortical cytoskeletal rearrangement in a PIP2‐dependent manner downstream of tyrosine kinases. , 1996, The EMBO journal.
[29] I. Gout,et al. Wiskott–Aldrich syndrome protein (WASp) is a binding partner for c-Src family protein-tyrosine kinases , 1996, Current Biology.
[30] L. Notarangelo,et al. Studies of the expression of the Wiskott-Aldrich syndrome protein. , 1996, The Journal of clinical investigation.
[31] D. Alexander,et al. CD45-null transgenic mice reveal a positive regulatory role for CD45 in early thymocyte development, in the selection of CD4+CD8+ thymocytes, and B cell maturation , 1996, The Journal of experimental medicine.
[32] U. Francke,et al. Wiskott–Aldrich Syndrome Protein, a Novel Effector for the GTPase CDC42Hs, Is Implicated in Actin Polymerization , 1996, Cell.
[33] C. Clendenin,et al. Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB , 1996, Nature.
[34] Uno Lindberg,et al. Two GTPases, Cdc42 and Rac, bind directly to a protein implicated in the immunodeficiency disorder Wiskott–Aldrich syndrome , 1996, Current Biology.
[35] A. Marcilla,et al. Wiskott-Aldrich syndrome protein physically associates with Nck through Src homology 3 domains , 1995, Molecular and cellular biology.
[36] V. Maino,et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. , 1995, Blood.
[37] J. Chant,et al. Regulation of the polarization of T cells toward antigen-presenting cells by Ras-related GTPase CDC42. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[38] C. Nobes,et al. Rho, Rac, and Cdc42 GTPases regulate the assembly of multimolecular focal complexes associated with actin stress fibers, lamellipodia, and filopodia , 1995, Cell.
[39] M. Barbacid,et al. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+CDS+thymocytes , 1995, Nature.
[40] F. Alt,et al. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene , 1995, Nature.
[41] K. Rajewsky,et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav , 1995, Nature.
[42] A. Lanzavecchia,et al. Sustained signaling leading to T cell activation results from prolonged T cell receptor occupancy. Role of T cell actin cytoskeleton , 1995, The Journal of experimental medicine.
[43] K. Sullivan,et al. A multiinstitutional survey of the Wiskott-Aldrich syndrome. , 1994, The Journal of pediatrics.
[44] C. Saint‐Ruf,et al. Analysis and expression of a cloned pre-T cell receptor gene. , 1994, Science.
[45] U. Francke,et al. Isolation of a novel gene mutated in Wiskott-Aldrich syndrome , 1994, Cell.
[46] K. Siminovitch,et al. Molecular characterization of the X-linked immunodeficiency diseases , 1994 .
[47] C. Terhorst,et al. T cells of patients with the Wiskott-Aldrich syndrome have a restricted defect in proliferative responses. , 1993, Journal of immunology.
[48] V. Stewart,et al. RAG-2-deficient blastocyst complementation: an assay of gene function in lymphocyte development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[49] A. Zlotnik,et al. A developmental pathway involving four phenotypically and functionally distinct subsets of CD3-CD4-CD8- triple-negative adult mouse thymocytes defined by CD44 and CD25 expression. , 1993, Journal of immunology.
[50] R. Perlmutter,et al. A dominant‐negative transgene defines a role for p56lck in thymopoiesis. , 1993, The EMBO journal.
[51] W. Swat,et al. CD 69 expression during selection and maturation of CD4+8+ thymocytes , 1993, European journal of immunology.
[52] G. Mills,et al. Evidence for defective transmembrane signaling in B cells from patients with Wiskott-Aldrich syndrome. , 1992, The Journal of clinical investigation.
[53] R. Bronson,et al. Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.
[54] K. Weinberg,et al. Altered O-glycan synthesis in lymphocytes from patients with Wiskott- Aldrich syndrome , 1991, The Journal of experimental medicine.
[55] J. Dennis,et al. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome. , 1991, The Journal of biological chemistry.
[56] J. Dennis,et al. Altered expression of leucocyte sialoglycoprotein in Wiskott-Aldrich syndrome is associated with a specific defect in O-glycosylation. , 1989, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[57] T. Morio,et al. The increase of non-MHC-restricted cytotoxic cells (γδ-TCR-bearing T cells or NK cells) and the abnormal differentiation of B cells in Wiskott-Aldrich syndrome , 1989 .
[58] R. Testi,et al. Leu 23 induction as an early marker of functional CD3/T cell antigen receptor triggering. Requirement for receptor cross-linking, prolonged elevation of intracellular [Ca++] and stimulation of protein kinase C. , 1989, Journal of immunology.
[59] K. Siminovitch,et al. X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect. , 1989, Genomics.
[60] R. Parkman,et al. Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome. , 1986, Blood.
[61] Y. Misumi,et al. Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes. , 1986, The Journal of biological chemistry.
[62] P. Rabinovitch,et al. Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry. , 1986, Journal of immunology.
[63] M. Condorelli,et al. The Wiskott‐Aldrich syndrome: studies of platelets, basophils and polymorphonuclear leucocytes , 1986, British journal of haematology.
[64] B. Golding,et al. Newborn and Wiskott-Aldrich patient B cells can be activated by TNP-Brucella abortus: evidence that TNP-Brucella abortus behaves as a T-independent type 1 antigen in humans. , 1984, Journal of immunology.
[65] E. Nishida,et al. Cofilin, a protein in porcine brain that binds to actin filaments and inhibits their interactions with myosin and tropomyosin. , 1984, Biochemistry.
[66] E. Unanue,et al. Ligand-induced association of surface immunoglobulin with the detergent-insoluble cytoskeletal matrix of the B lymphocyte. , 1982, Journal of immunology.
[67] L. Harker,et al. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets , 1980 .
[68] H. Ochs,et al. The Wiskott-Aldrich syndrome: studies of lymphocytes, granulocytes, and platelets. , 1980, Blood.
[69] J. Harley,et al. Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection. , 1980, Blood.
[70] D. Stites,et al. The Wiskott-Aldrich syndrome. Immunologic studies in nine patients and selected family members. , 1975, Cellular immunology.
[71] T. Hovig,et al. Wiskott—Aldrich Syndrome: Qualitative Platelet Defects and Short Platelet Survival , 1969, British journal of haematology.
[72] M. Cooper,et al. Wiskott-Aldrich syndrome: An immunologic deficiency disease involving the afferent limb of immunity , 1968 .
[73] Aldrich Ra,et al. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. , 1954 .
[74] D. C. Campbell,et al. Pedigree demonstrating a sex-linked recessive condition characterized by draining ears, eczematoid dermatitis and bloody diarrhea. , 1954, Pediatrics.